CLS-LOGO-New2021.jpg
CLS Americas Presents its TRANBERG™ System for Image-Guided Focal Laser Ablation at Focal Therapy Society 2023 Conference
07 sept. 2023 08h49 HE | Clinical Laserthermia Systems Americas, Inc.
WASHINGTON, Sept. 07, 2023 (GLOBE NEWSWIRE) -- CLS Americas, a leading provider of office-based, focal laser ablation systems in the US urology market, today announced it will exhibit its TRANBERG™...
CLS-Logo-1.jpg
CLS Exhibits MRI-Guided, Focal Laser Ablation System for Prostate Cancer at the 94th National Congress of the Italian Society of Urology
15 oct. 2021 04h00 HE | Clinical Laserthermia Systems Americas, Inc.
RICCIONE, Italy, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it will present its high precision, image-guided TRANBERG® Laser Thermal Therapy...
CLS-Logo-1.jpg
CLS Strengthens its Organization with New Employees in Key Positions for Continued Global Establishment
13 janv. 2021 03h00 HE | Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), a developer of advanced innovative products for high-precision, image-guided laser ablation, today...
CLS-Logo-1.jpg
CLS and Toronto General Hospital Continue Clinical Trial Collaboration Regarding MRI-Guided Laser Ablation Treatment of Prostate Cancer
17 nov. 2020 05h00 HE | Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), today announced the clinical study performed in collaboration with Toronto General Hospital, Canada,...
CLS-Logo-1.jpg
CLS Receives New CPT® Reimbursement Code Approval by American Medical Association for Ultrasound-Guided Focal Laser Ablation of Prostate Cancer
04 nov. 2020 02h30 HE | Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), today announced the American Medical Association (AMA) has approved its application and issued a...
CLS-Logo-1.jpg
CLS and University Hospital Magdeburg launch clinical trial regarding focal laser ablation treatment of localized prostate cancer
12 oct. 2020 02h30 HE | Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems (publ) and Otto-von-Guericke-University Magdeburg, Medical faculty are entering into an agreement regarding an...
CLS-Logo-1.jpg
CLS and Advanced Medical Systems Form Joint Venture Cooperation, Introducing the Innovative TRANBERG® Thermal Therapy System and imILT® in the Asia-Pacific Region
24 août 2020 03h00 HE | Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of innovative image-guided laser ablation technology for minimally invasive soft tissue and...
CLS-Logo-1.jpg
CLS Conducts In-Vivo Laser Ablation Studies for Neuro and Prostate using TRANBERG Thermal Therapy System with Thermoguide
22 mai 2020 04h00 HE | Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif. and LUND, Sweden, May 22, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it is conducting new in-vivo precision laser ablation treatment...
CLS-Logo-1.jpg
CLS Granted New U.S. Patent Covering Unique, Non-Cooled, Diffuser-type Laser Ablation Applicator
29 avr. 2020 07h00 HE | Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif. and LUND, Sweden, April 29, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it was granted a new U.S. Patent valid until 2036 covering its...